Edwards Lifesciences Corporation(NYSE:EW)の株価は、同社が2Q売上高の予想を下回り、3Qガイダンスも予想を下回ったことを受けて、木曜日のセッション中に急落しまし...
ログインすると全部閲覧できます。
ログイン
Shares ofEdwards Lifesciences Corporation(NYSE:EW) fell sharply during Thursday's session after the company reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix.
Edwards Lifesciences reported quarterly earnings of 70 cents per share which beat the analyst consensus estimate of 69 cents per share. The company reported quarterly sales of $1.632 billion which missed the analyst consensus estimate of $1.653 billion.
Edwards Lifesciences shares dipped 26.9% to $63.60 on Thursday.
Here are some other stocks moving in today's mid-day session.
Edwards Lifesciences Corporation(NYSE:EW)の株価は、同社が2Q売上高の予想を下回り、3Qガイダンスも予想を下回ったことを受けて、木曜日のセッション中に急落しまし...
ブラウザの共有ボタンを使って、このページを友人と共有することができます。